Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CXCL2 |
| Upstream (Parents) |
|---|
| (<<) CASP4 → CXCL2 |
| (<<) CAV1 → CXCL2 |
| (<<) CHST7 → CXCL2 |
| (<<) CLEC2B → CXCL2 |
| (<<) DAB2 → CXCL2 |
| (<<) EGFR → CXCL2 |
| (<<) EGR1 → CXCL2 |
| (<<) FOS → CXCL2 |
| (<<) GNAQ → CXCL2 |
| (<<) HS2ST1 → CXCL2 |
| (<<) HSP90AA1 → CXCL2 |
| (<<) KCTD12 → CXCL2 |
| (<<) MAP3K8 → CXCL2 |
| (<<) NNMT → CXCL2 |
| (<<) PTGER4 → CXCL2 |
| (<<) RAB5B → CXCL2 |
| (<<) RECK → CXCL2 |
| (<<) SGK1 → CXCL2 |
| (<<) SPRY2 → CXCL2 |
| (<<) ZFP36 → CXCL2 |
| Downstream (Children) |
|---|
| CXCL2 → CXCL1 (>>) |
| CXCL2 → EFEMP1 (>>) |
| CXCL2 → EPN3 (>>) |
| CXCL2 → ETS2 (>>) |
| CXCL2 → GNG4 (>>) |
| CXCL2 → HBEGF (>>) |
| CXCL2 → HDAC5 (>>) |
| CXCL2 → IL6 (>>) |
| CXCL2 → ISG20 (>>) |
| CXCL2 → MAFF (>>) |
| CXCL2 → MAP3K4 (>>) |
| CXCL2 → PAK6 (>>) |
| CXCL2 → PRKAA1 (>>) |
| CXCL2 → PTGS2 (>>) |
| CXCL2 → RND3 (>>) |
| CXCL2 → ROBO3 (>>) |
| CXCL2 → SLPI (>>) |
| CXCL2 → SOD2 (>>) |
| CXCL2 → TFPI2 (>>) |
| CXCL2 → TNXB (>>) |
| CXCL2 → UBE2C (>>) |
| CXCL2 → UPP1 (>>) |
